The stock of Aspen Aerogels Inc (ASPN) has seen a -14.17% decrease in the past week, with a -25.84% drop in the past month, and a -58.57% decrease in the past quarter. The volatility ratio for the week is 13.25%, and the volatility levels for the past 30 days are at 7.08% for ASPN. The simple moving average for the past 20 days is -15.83% for ASPN’s stock, with a -67.90% simple moving average for the past 200 days.
Is It Worth Investing in Aspen Aerogels Inc (NYSE: ASPN) Right Now?
Aspen Aerogels Inc (NYSE: ASPN) has a price-to-earnings ratio that is above its average at 35.43x. The stock has a 36-month beta value of 2.62. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ASPN is 80.69M, and at present, short sellers hold a 11.06% of that float. On April 10, 2025, the average trading volume of ASPN was 1.97M shares.
ASPN) stock’s latest price update
The stock of Aspen Aerogels Inc (NYSE: ASPN) has increased by 9.76 when compared to last closing price of 5.02. Despite this, the company has experienced a -14.17% fall in its stock price over the last five trading sessions. seekingalpha.com reported 2025-03-31 that Aspen Aerogels’ growth is tied to the EV market, which faces uncertainty due to potential elimination of the EV tax credit. Despite fears, Aspen Aerogels may benefit from Tesla’s declining market share, as smaller EV players gain traction, particularly in Europe and China. US EV sales are expected to plateau until 2027, potentially limiting Aspen’s revenue growth. But international markets offer expansion opportunities.
Analysts’ Opinion of ASPN
Many brokerage firms have already submitted their reports for ASPN stocks, with TD Cowen repeating the rating for ASPN by listing it as a “Buy.” The predicted price for ASPN in the upcoming period, according to TD Cowen is $11 based on the research report published on March 07, 2025 of the current year 2025.
Barclays gave a rating of “Overweight” to ASPN, setting the target price at $27 in the report published on August 06th of the previous year.
ASPN Trading at -32.54% from the 50-Day Moving Average
After a stumble in the market that brought ASPN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.38% of loss for the given period.
Volatility was left at 7.08%, however, over the last 30 days, the volatility rate increased by 13.25%, as shares sank -25.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -51.62% lower at present.
During the last 5 trading sessions, ASPN fell by -14.17%, which changed the moving average for the period of 200-days by -78.20% in comparison to the 20-day moving average, which settled at $6.55. In addition, Aspen Aerogels Inc saw -53.62% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ASPN starting from Young Donald R, who sale 63,355 shares at the price of $30.03 back on Sep 30 ’24. After this action, Young Donald R now owns 483,640 shares of Aspen Aerogels Inc, valued at $1,902,551 using the latest closing price.
Donald R. Young, the President, CEO, Director of Aspen Aerogels Inc, proposed sale 134,629 shares at $27.62 during a trade that took place back on Sep 30 ’24, which means that Donald R. Young is holding shares at $3,718,452 based on the most recent closing price.
Stock Fundamentals for ASPN
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.4 for the gross margin
The net margin for Aspen Aerogels Inc stands at 0.03. The total capital return value is set at 0.07. Equity return is now at value 2.43, with 1.67 for asset returns.
Based on Aspen Aerogels Inc (ASPN), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at 0.44. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is 4.51.
Currently, EBITDA for the company is 49.57 million with net debt to EBITDA at -0.83. When we switch over and look at the enterprise to sales, we see a ratio of 0.74. The receivables turnover for the company is 4.15for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.72.
Conclusion
To sum up, Aspen Aerogels Inc (ASPN) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
